Department of Human Medicine, Institute of General Practice and Family Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
Institute of General Practice, Rostock University Medical Center, Rostock, Germany.
J Am Med Inform Assoc. 2019 Nov 1;26(11):1323-1332. doi: 10.1093/jamia/ocz104.
We sought to investigate the experiences of general practitioners (GPs) with an electronic decision support tool to reduce inappropriate polypharmacy in older patients (the PRIMA-eDS [Polypharmacy in chronic diseases: Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support] tool) in a multinational sample of GPs and to quantify the findings from a prior qualitative study on the PRIMA-eDS-tool.
Alongside the cluster randomized controlled PRIMA-eDS trial, a survey was conducted in all 5 participating study centers (Bolzano, Italy; Manchester, United Kingdom; Salzburg, Austria; Rostock, Germany; and Witten, Germany) between October 2016 and July 2017. Data were analyzed using descriptive statistics and chi-square tests.
Ninety-one (n = 160) percent of the 176 questionnaires were returned. Thirty-two percent of the respondents reported that they did not cease drugs because of the medication check. The 68% who had discontinued drugs comprise 57% who had stopped on average 1 drug and 11% who had stopped 2 drugs or more per patient. The PRIMA-eDS tool was found to be useful (69%) and the recommendations were found to help to increase awareness (86%). The greatest barrier to implementing deprescribing recommendations was the perceived necessity of the medication (69%). The majority of respondents (65%) would use the electronic medication check in routine practice if it was part of the electronic health record.
GPs generally viewed the PRIMA-eDS medication check as useful and as informative. Recommendations were not always followed due to various reasons. Many GPs would use the medication check if integrated into the electronic health record.
我们旨在调查全科医生(GP)使用电子决策支持工具(PRIMA-eDS[慢性病中的多药治疗:通过电子决策支持减少老年人中的不适当用药和不良药物事件]工具)减少老年患者不适当的多药治疗的经验,该研究采用多国 GP 样本,并对 PRIMA-eDS 工具的先前定性研究结果进行量化。
在 PRIMA-eDS 试验的集群随机对照研究中,2016 年 10 月至 2017 年 7 月期间,在所有 5 个参与研究中心(意大利博尔扎诺、英国曼彻斯特、奥地利萨尔茨堡、德国罗斯托克和德国维滕)进行了一项调查。使用描述性统计和卡方检验分析数据。
在 176 份问卷中,有 160 份(91%)被收回。32%的受访者表示,他们没有因为药物检查而停止用药。有 68%的人停止了药物治疗,其中 57%的人平均停用了 1 种药物,11%的人每例患者停止了 2 种或更多药物。PRIMA-eDS 工具被认为是有用的(69%),建议被认为有助于提高认识(86%)。实施减少药物剂量建议的最大障碍是认为药物有必要(69%)。大多数受访者(65%)表示,如果该电子药物检查成为电子健康记录的一部分,他们将在常规实践中使用该电子药物检查。
GP 普遍认为 PRIMA-eDS 药物检查是有用和信息丰富的。由于各种原因,并非所有建议都得到遵循。如果将药物检查集成到电子健康记录中,许多 GP 将会使用该药物检查。